SS Innovations International (SSII) Cash from Financing Activities (2016 - 2026)
SS Innovations International (SSII) posted Cash from Financing Activities of $18.2 million for Q1 2026, up 1222.47% sequentially from $1.4 million in Q4 2025, and down 18.95% YoY from $22.4 million in Q1 2025.
SS Innovations International (SSII) Cash from Financing Activities (2016 - 2026) Analysis & Trends
SS Innovations International has reported Cash from Financing Activities for 11 years, with the latest figure at $18.2 million in Q1 2026.
- Quarterly Cash from Financing Activities fell 18.95% year-over-year to $18.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $21.9 million (down 24.91% YoY) and the FY2025 annual result came in at $26.2 million, up 177.6% from the prior year.
- Cash from Financing Activities climbed to $18.2 million in Q1 2026 per SSII's latest filing, from $1.4 million in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $22.4 million in Q1 2025 and troughed at -$702098.0 in Q2 2025.
- A 5-year average of $5.4 million and a median of $2.7 million in 2024 frame the typical range for Cash from Financing Activities.
- The sharpest annual moves came in 2022 and 2025: Cash from Financing Activities jumped 15516.71% in 2022, then sank 126.45% in 2025.
- Over 5 years, Cash from Financing Activities stood at $3.1 million in 2022, then slumped by 95.1% to $150563.0 in 2023, then soared by 2165.52% to $3.4 million in 2024, then slumped by 59.74% to $1.4 million in 2025, then soared by 1222.47% to $18.2 million in 2026.
- According to Business Quant data, Cash from Financing Activities over the past three periods registered $18.2 million, $1.4 million, and $3.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | -95.00 Mn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | -410.00 Mn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | -300,000.00 |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | -607.30 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | -236.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -1.34 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | -213.50 Mn |
| 10 | SS Innovations International | 714.49 Mn | 692.19 Mn | 7.10 Mn | 3.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.48 Mn |
| Jun 30, 2026 | 3.48 Mn |
| Mar 31, 2026 | 18.16 Mn |
| Mar 31, 2026 | 18.16 Mn |
| Dec 31, 2025 | 1.37 Mn |
| Dec 31, 2025 | 1.37 Mn |
| Sep 30, 2025 | 3.09 Mn |
| Sep 30, 2025 | 3.09 Mn |
| Jun 30, 2025 | -702,098.00 |
| Jun 30, 2025 | -702,098.00 |
| Mar 31, 2025 | 22.41 Mn |
| Mar 31, 2025 | 22.41 Mn |
| Dec 31, 2024 | 3.41 Mn |
| Dec 31, 2024 | 3.41 Mn |
| Sep 30, 2024 | 722,336.00 |
| Sep 30, 2024 | 722,336.00 |
| Jun 30, 2024 | 2.65 Mn |
| Jun 30, 2024 | 2.65 Mn |
| Mar 31, 2024 | 2.64 Mn |
| Mar 31, 2024 | 2.64 Mn |